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Cardiovascular Disease (CVD) risk reduction is based on treating modifiable 
risk factors such as dyslipidaemia, hypertension, diabetes and smoking. 
Clustering of risk factors in individuals is often evident.
   Evidence suggests this approach will lead to risk reduction though the 
reduction seen in RCTs may not be obtained in routine care.
Currently there is no non-invasive method to study cumulative risk reduction 
when multifaceted risk reduction interventions are applied.
   Vascular wall properties such as endothelial function, inflammation 
and smooth muscle proliferation are important in the pathogenesis of 
atherosclerosis (Fig 1).
   Both CVD risk and protective factors influence endothelial integrity .
Endothelial dysfunction is considered to be reversible by risk factor 
modification.
   Vascular flow patterns can be affected by characteristics of the arterial wall 
and endothelial dysfunction and vice versa (Fig 1).
Introduction
To develop a robust method to study characteristics of vascular flow using 
ultrasound  to assess endothelial function and vasodilatation.
There are four stages:  
1. To standardise and validate the methodology to enable computational 
risk flow data and other flow characteristics to be used clinically. (Current 
Study). Further development of fluid modelling methods will enable 
investigation of particulate haemodynamics (Fig 2).     
2. To study different patient groups to investigate associations between the 
derived vascular flow measurents and estimated risk .
3. Use prospective studies to establish if computational flow dynamic data 
can predict outcome following treatment in patient groups. 
4.  Our recent presentation at the ADA shows significant reduction 
in mortality in type 2 diabetics treated with PDE5 inhibitors (Fig 3). 
Mechanism is unknown. PDE5Is are potent vasodilators with beneficial 
effects on endothelial function and putative cardio-protective properties. 
Endothelial benefits from PDE5Is may occur at lower doses than required 
to improve sexual health.
Vascular flow studies may be useful in gaining an understanding of these 
findings
Aim of the Study
The common carotid artery is of significant pathological importance with 
respect to stenosis and flow prior to the bifurcation. 
The lack of a coherent methodology protocol for ultrasound  (to standardise 
the measurement of plaque) was addressed in 2009 with the publication of 
‘Joint recommendations for Reporting Carotid Ultrasound Investigations in 
the United Kingdom’.
The following characteristics of vascular flow will be assessed by ultrasound 
measurements of velocities at peak systole and at end diastole at different 
locations in the carotid artery (52 individuals; 26 with IHD and 26 healthy 
volunteers).
 1. Velocity & Velocity Gradient 
 2. Dynamic Velocity Profiles 
 3. Wall Shear Stress
 4. Dilation & Artery Stiffness 
Method
Velocity will be measured at equidistant 
intervals across the vessel diameter. The 
flow will be measured in a line across the 
lumen in the direction of flow. This will be 
at 90 degrees to the wall when no plaque 
is present.
Current limitations & difficulties:
 » Minimum distance between     
measurement point ~ 0.5mm.
 » Consistency of intervals operator    
dependent.
 » Measurement line may not be perpendicular to vessel wall if plaque is   
 present,
Velocity & Velocity Gradient Evaluation
The velocity profile in straight pipes at steady state is parabolic.
Due to the pulsatile nature of blood flow  velocity profiles are very different 
and indeed vary significantly over the  cardiac cycle .
Dynamic Velocity Profiles
Calculated velocity profiles from 
measured pressure gradients in 
the femoral artery in the dog 
(Blood Flow in Arteries, D.A. 
McDonald, 2nd Ed., 1974)
Wall Shear Stress Evaluation
Changes to the endothelial surface layer, the glycocalyx, are the precursor to 
vascular injury and atherosclerosis. Both typically develop at branches and 
bends in the arterial tree that are exposed to disturbed patterns of blood 
flow. 
The glycocalyx provides a barrier against leakage of fluid, proteins and lipids 
across the vascular wall. In addition it modulates the adhesion process of 
inflammatory cells and platelets to the endothelial surface, and it functions 
as a sensor and mechanotransducer of the fluid shear forces to which the 
endothelium is exposed and which is the trigger for the release of nitric oxide 
(NO).
There is experimental evidence that hyperglycaemia causes damage to the 
vascular glycocalyx .
Vink et al have shown that glucose itself alters the structure of the glycocalyx .
Adapted from Wentzel JJ, Chatzizisis YS, Gijsen FHJ, Giannoglou GD, 
Feldman CL, Stone PH. Cardiovascular Research 2012; 96: 234–243.
Arteries are known to become  stiffer and less flexible as we age.  This 
manifests itself in higher blood pressure values  and higher pulse wave 
velocities (PWV) due to the pulse wave being less well absorbed.
Artery stiffness to be determined noninvasively by measuring change in 
diameter by US and blood pressure measurement.
Studies using aortic PWV measurements found PWV to be significantly 
higher in hypertensive-diabetics compared to patients with diabetes or high 
blood pressure alone, and in turn, PWV in these patients were  found to be 
higher than in healthy controls. Thus, the additive nature of hypertension 
and diabetes to cardiovascular risk is reflected by abnormalities in PWV 
measurements.
Distensibility/Stiffness of Arteries
Figure 1. A diagrammatic representation of atherosclerosis and risk factors, 
both local and systemic, with resulting disrupted vascular flow
Disrupted blood flow  leading to 
decreased shear stress around curvature of 
vessel
Modifiable Risk Factors
Diabetes
Hypertension
Dyslipidaemia
Smoking
Factors affecting the Endothelium
↓eNOS
↓ Endothelial repair
↓ROS
Inflammation
↓ Lipoprotein permeability
↓ Leukocyte adhesion
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Figure 2. Particulate haemodynamics affecting flow dynamics
A basic science approach to blood flow simulation using explicitly 
resolved cellular component avoids use of empirical models: is the 
only way correctly to account for interaction with vessel boundary- 
as cells pass endothelial location, WSS fluctuates. There is no such 
thing as steady haemodynamic flow. 
The membrane makes RBC behaviour more complicated than e.g. 
a drop of oil in water, because its membrane imparts a preferred 
curvature, a bending rigidity and conserved area leading to the 
bicuspid shape seen evolving to the left. To obtain correct fluid 
dynamics all these properties must be considered.
These constraints gives rise to different phenomena ...
• tumbling 
• tank treading
• deformation
• lift
Problem of blood flow is mathematically intensive: need 
to account  for flow of internal and external fluids and the 
constraining effect of membrane (method must have physical 
accuracy) AND need to be able to simulate many cells without loss 
of efficiency and accuracy. Necessitates use of niche CFD methods. 
We will use lattice Boltzmann equation simulation
Figure 3. Data presented at the American Diabetes Association Boston, June 5th-9th 2015.   
 Testosterone Replacement Therapy and Phosphodiesterase 5 Inhibitor use are independently 
associated with a reduction in All-Cause Mortality in men with Type 2 Diabetes 
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Biological vesicles - fluid filled sacks 
separated by a bilayer = 2D 
incompressible fluid.
The boundary conditions between 
the fluids are now different. 
surface tension
conservation of volume
conservation of area
bending rigidity 
Colour indicates relative 
pressure
Parallel LB simulation on 
100 
node Beowulf Cluster
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